Literature DB >> 21484412

Antiproliferative effect of estrogen in vascular smooth muscle cells is mediated by Kruppel-like factor-4 and manganese superoxide dismutase.

Derya Sivritas1, Marc Ulrich Becher, Talin Ebrahimian, Omar Arfa, Stephanie Rapp, Annika Bohner, Cornelius Friedrich Mueller, Takashi Umemura, Sven Wassmann, Georg Nickenig, Kerstin Wassmann.   

Abstract

The mitochondrial antioxidant enzyme manganese superoxide dismutase (MnSOD) and the zinc finger transcription factor Kruppel-like factor-4 (KLF4) are involved in the regulation of redox homeostasis, apoptosis and cell proliferation. We have shown that estrogen exerts antioxidative actions via induction of MnSOD in cultured rat aortic vascular smooth muscle cells (VSMC). The purpose of the present study was to investigate whether estrogen inhibits VSMC proliferation via alteration of KLF4 and MnSOD expression. In cultured rat aortic VSMC, estrogen binding to estrogen receptor-alpha led to rapid increase in KLF4 expression and reduction of cell proliferation by 50%. Protein separation revealed that KLF4 was shifted to the nucleus when VSMC were treated with estrogen. Estrogen-mediated induction of KLF4 and the antiproliferative effect involved activation of PI-3 kinase, Akt phosphorylation and induction of NO synthase activity. Experiments in freshly isolated denuded aortic segments revealed an increase in KLF4 abundance after estrogen treatment and demonstrated that eNOS is expressed in the media at low levels. Transfection experiments showed that estrogen-induced overexpression of MnSOD required KLF4 and that both KLF4 and MnSOD were indispensable for the observed antiproliferative effect of estrogen in VSMC. To confirm these data in vivo, we investigated neointima formation after carotid artery injury in wild-type (WT) and MnSOD+/- mice. Estrogen deficiency led to enhanced neointima formation and higher numbers of Ki67-positive proliferating cells in the neointima of ovariectomized WT and MnSOD+/- mice. Moreover, MnSOD+/- mice showed more extensive neointima formation and Ki67 immunostaining. Interestingly, estrogen replacement prevented neointima formation in WT mice but failed to completely inhibit neointima formation in MnSOD+/- mice. Cultured VSMC derived from MnSOD+/- mice showed enhanced proliferation as compared to WT VSMC, and estrogen treatment failed to inhibit proliferation in MnSOD+/- VSMC. In conclusion, these data demonstrate the importance of MnSOD and KLF4 for proliferation control in VSMC. Our results provide novel insights into how proliferation of VSMC is regulated by estrogen and may help to identify novel targets for the treatment of vascular diseases such as restenosis.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21484412     DOI: 10.1007/s00395-011-0174-z

Source DB:  PubMed          Journal:  Basic Res Cardiol        ISSN: 0300-8428            Impact factor:   17.165


  12 in total

1.  Rapid estrogen receptor signaling mediates estrogen-induced inhibition of vascular smooth muscle cell proliferation.

Authors:  Kazutaka Ueda; Qing Lu; Wendy Baur; Mark J Aronovitz; Richard H Karas
Journal:  Arterioscler Thromb Vasc Biol       Date:  2013-06-06       Impact factor: 8.311

Review 2.  Sexual dimorphism in cardiac remodeling: the molecular mechanisms ruled by sex hormones in the heart.

Authors:  Cláudia Ferreira; Fábio Trindade; Rita Ferreira; João Sérgio Neves; Adelino Leite-Moreira; Francisco Amado; Mário Santos; Rita Nogueira-Ferreira
Journal:  J Mol Med (Berl)       Date:  2021-11-23       Impact factor: 4.599

Review 3.  G-protein-coupled estrogen receptor as a new therapeutic target for treating coronary artery disease.

Authors:  Guichun Han; Richard E White
Journal:  World J Cardiol       Date:  2014-06-26

4.  Vascular Aging in Women: is Estrogen the Fountain of Youth?

Authors:  Susana Novella; Ana Paula Dantas; Gloria Segarra; Pascual Medina; Carlos Hermenegildo
Journal:  Front Physiol       Date:  2012-06-06       Impact factor: 4.566

5.  Estrogen modulates vascular smooth muscle cell function through downregulation of SIRT1.

Authors:  Chien-Hsing Lee; Sheng-Chiang Su; Chi-Fu Chiang; Chu-Yen Chien; Chia-Chen Hsu; Tzu-Yi Yu; Shih-Ming Huang; Yi-Shing Shieh; Hong-Wei Kao; Chien-Sung Tsai; Yi-Jen Hung; Chih-Yuan Lin
Journal:  Oncotarget       Date:  2017-11-10

6.  LH-induced Transcriptional Regulation of Klf4 Expression in Granulosa Cells Occurs via the cAMP/PKA Pathway and Requires a Putative Sp1 Binding Site.

Authors:  Hyeonhae Choi; Jaesook Roh
Journal:  Int J Mol Sci       Date:  2020-10-06       Impact factor: 5.923

7.  Therapeutic effects of water soluble danshen extracts on atherosclerosis.

Authors:  Yoon Hee Cho; Cheol Ryong Ku; Zhen-Yu Hong; Ji Hoe Heo; Eun Hee Kim; Dong Hoon Choi; Dongkyu Kim; Ae-Jung Kim; Cheol Soon Lee; Mankil Jung; Hyun Chul Lee; Miran Seo; Eun Jig Lee
Journal:  Evid Based Complement Alternat Med       Date:  2013-01-16       Impact factor: 2.629

8.  Activation of GPER Induces Differentiation and Inhibition of Coronary Artery Smooth Muscle Cell Proliferation.

Authors:  Fen Li; Xuan Yu; Claudia K Szynkarski; Cong Meng; Beiyan Zhou; Rola Barhoumi; Richard E White; Cristine L Heaps; John N Stallone; Guichun Han
Journal:  PLoS One       Date:  2013-06-19       Impact factor: 3.240

9.  Liuwei Dihuang, a traditional Chinese medicinal formula, inhibits proliferation and migration of vascular smooth muscle cells via modulation of estrogen receptors.

Authors:  Yayun Zhang; Xing Qian; Xin Sun; Chao Lin; Yi Jing; Yuan Yao; Zhi Ma; Meiyu Kuai; Ying Lu; Xueyun Kong; Qi Chen; Xiang Wu; Xuan Zhao; Yu Li; Huimin Bian
Journal:  Int J Mol Med       Date:  2018-04-16       Impact factor: 4.101

Review 10.  Cellular and Molecular Differences between HFpEF and HFrEF: A Step Ahead in an Improved Pathological Understanding.

Authors:  Steven J Simmonds; Ilona Cuijpers; Stephane Heymans; Elizabeth A V Jones
Journal:  Cells       Date:  2020-01-18       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.